CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 91 enrolled
Drug / intervention
Acceptance and Commitment Therapy +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02611544
NCT02611544N/ACompleted

Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors: A Randomized Clinical Pilot Trial

Indiana University·interventional·Posted Nov 20, 2015·Updated Jun 26, 2019

In Brief

A clinical study evaluating Acceptance and Commitment Therapy, Survivorship Education, and 1 other intervention for Breast Neoplasms and 16 related conditions. Completed, enrolled 91 participants across 1 site.

Detailed Summary

Fear of cancer recurrence (FCR) is one of the most prevalent, persistent, and disruptive sources of distress for adult cancer survivors. Prevalence rates for FCR have been estimated at up to 89%, with approximately half of cancer survivors reporting clinically significant levels of FCR. Despite the recognized prevalence, persistence, and suffering associated with FCR, effective and accessible treatments for FCR are lacking and urgently needed. Our long-term goal is to develop, evaluate, and implement effective behavioral interventions for cancer survivors suffering with FCR.

Study Details

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 20, 2015
Enrollment StartDec 1, 2015
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 10.6 years ago

Interventions

Acceptance and Commitment Therapybehavioral

6-week ACT intervention group (n=33)

Survivorship Educationbehavioral

6-week survivorship education group (SE; n=32)

Enhanced Usual Carebehavioral

enhanced usual care (EUC; n=26)